TME Pharma reveals positive NOX-A12 data
GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients
Read More
Tag: NOX-A12
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
